Metrics as of 10/17/2026, 07:46 AM (Berlin time), refresh in progress.
ICU Medical Stock
ICU Medical, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Vivek Jain
- Employees
- 13,000
- Market cap
- $4.1 B
- IPO
- 31/03/1992
ICU Medical, Inc. is a medical technology firm headquartered in San Clemente, California, operating within the Healthcare sector. Established in 1984, the company specializes in the development, manufacture, and sale of devices for infusion therapy and critical care. The product line for infusion therapy includes…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
ICU Medical stock: price history
1D
-2.5%
1W
+1.7%
1M
+4.7%
6M
+25.4%
YTD
+14.2%
1Y
+39.9%
2Y
-11.3%
5Y
-29.4%
10Y
+10.7%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~79% stronger price swings than usual
ICU Medical stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
1 more assignment (Enabler/Second row) Pro-only.
ICU Medical is a medical technology company specializing in the development and distribution of products for infusion therapy and intensive care medicine. Its portfolio comprises medical hardware such as infusion pumps and hemodynamic monitoring systems, as well as specialized software designed to enhance patient safety through integration into hospital information systems. A substantial portion of the business model is derived from consumables including catheters, connectors, and intravenous solutions. The customer base spans a broad spectrum of healthcare providers, ranging from acute care hospitals and ambulatory clinics to home care settings.
- Revenue model
- Mixed
- Recurring revenue
- High
- Pricing power
- Strong
- Moat
- Wide
- Moat type
- Switching costs
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about ICU Medical
Analyst assessment of ICU Medical
PRICE TARGET LOW
US$163.00
CONSENSUS
US$186.40
MEDIAN
US$187.00
PRICE TARGET HIGH
US$200.00
1
STRONG BUY
10
BUY
1
HOLD
0
SELL
0
STRONG SELL
12
TOTAL · Buy
As of: 07/08/2026
ICU Medical stock metrics
P/E
135.83
P/B
1.89
EV/EBITDA
20.39
RETURN ON EQUITY
0.9%
NET MARGIN
3.5%
DEBT/EQUITY
0.59
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
98.2%
FLOAT SHARES
24,556,661
AVG. DAILY VOLUME (30D)
243,212
Insider transactions (SEC)
Sanzone Virginia Ruth
Sanzone Virginia Ruth
Sanzone Virginia Ruth
Sanzone Virginia Ruth
Bonnell Brian Michael
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about ICU Medical stock
What does ICU Medical do?
ICU Medical, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Vivek Jain, the company employs around 13,000 people.
The IPO was on 31/03/1992; the stock trades on NASDAQ under the ticker ICUI.
What do analysts say about ICU Medical stock?
12 analysts rate the stock, the consensus is Buy (as of 07/08/2026).
The average price target is US$186.40, ranging from US$163.00 to US$200.00, with a median of US$187.00.
This is an external assessment, not a statement by Market Jury.
When does ICU Medical report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 79% stronger than usual.
Does ICU Medical pay a dividend?
No, ICU Medical currently does not pay a dividend.
Which stocks are comparable to ICU Medical?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get ICU Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess ICU Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.